A large body of published work shows that proton (hydrogen 1 [ 1 H]) magnetic resonance (MR)
spectroscopy has evolved from a research tool into a clinical neuroimaging modality. …

A recent joint meeting was held on January 30, 2014, with the US Food and Drug
Administration (FDA), National Cancer Institute (NCI), clinical scientists, imaging experts, …

Magnetic resonance spectroscopic imaging (MRSI) provides a noninvasive method of
detecting small molecular markers (historically the metabolites choline and citrate) within the …

Applying dental anatomy to the practice of dentistry, Wheeler’s Dental Anatomy, Physiology,
and Occlusion, 10th Edition provides illustrated coverage of dentitions, pulp formation, the …

Tumor recurrence is a leading cause of cancer mortality. Therapies for recurrent disease may
fail, at least in part, because the genomic alterations driving the growth of recurrences are …

… Nelson and colleagues therefore used a hyperpolarized form of pyruvate ([1- 13 C]pyruvate)
to sensitively image increased levels of its product, [1- 13 C]lactate, as well as the flux of …

PURPOSE: To evaluate if three-dimensional hydrogen-1 magnetic resonance spectroscopic
imaging (3D MRSI) when combined with a clinical MR imaging examination could …

An extraordinary new technique using hyperpolarized 13 C-labeled pyruvate and taking
advantage of increased glycolysis in cancer has the potential to improve the way magnetic …

PURPOSE: To assess the efficacy of combined magnetic resonance (MR) imaging and three-dimensional
(3D) proton MR spectroscopic imaging in the detection and localization of …

BACKGROUND AND PURPOSE: Tumor progression is often difficult to distinguish from
nonneoplastic treatment response on the basis of MR images alone. This study correlates …